Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, today announced it will provide its inactivated COVID-19 vaccine, CoronaVac® , to self-paying groups in Hong. | May 10, 2023
Supplemental Submission Pursuant to Item 16I of Form 20-F Sinovac Biotech Ltd. is submitting via EDGAR the following information as required under Item 16I of Form 20-F in. | May 1, 2023
Sinovac Biotech Ltd. , a leading provider of biopharmaceutical products in China, has filed its 2022 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended. | May 1, 2023
Attorney Advertising Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against 1Globe Capital LLC and certain of its officers, on behalf of all. | October 14, 2022
South Africa s health
regulator said on Monday it had approved a COVID-19 vaccine from
China s Sinopharm, although a senior health official said the
government was not planning to procure doses for. | February 7, 2022